|
|
Article: Crawford's Exit Leads To von Eschenbach As FDA Head.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - A surprising departure atop the FDA has Lester Crawford out as commissioner, just two months after he received Senate confirmation to permanently lead the agency, and some of his critics looking toward a fresh course at the government regulatory agency.
"The opportunity to name a new commissioner is a chance to take the agency in a necessary new direction," Sen. Chuck Grassley (R-Iowa) said in a statement. The chairman of the Committee on Finance, he has conducted FDA oversight during Crawford's tenure atop the agency and criticized a "too-cozy relationship with the pharmaceutical industry and an attitude of shielding ...